P&PAULSON & CO. INC.
Institutional investor · Portfolio as of Q2 2023
Top Holdings21 positions
Valeant Pharmaceuticals Intern | 26.4M | $211.5M | 20.6% | $20.74 | -62.24% | 15 qtrssince 2019-Q3 | Unchanged 0 |
BRIGHTSPHERE INVT GROUP INC | 9M | $187.5M | 18.3% | $9.52 | +118.24% | 15 qtrssince 2019-Q3 | Unchanged 0 |
Midas Gold Corp | 24.8M | $90.9M | 8.9% | $5.97 | -40.66% | 9 qtrssince 2021-Q1 | Unchanged 0 |
Novagold Resources Inc | 22.2M | $88.7M | 8.7% | $6.51 | -40.21% | 15 qtrssince 2019-Q3 | Unchanged 0 |
Madrigal Pharmaceuticals Inc | 350,200 | $80.9M | 7.9% | $231.00 | 0.00% | 1 qtr | New 93 |
| 3.8M | $80.8M | 7.9% | $4.23 | +25.80% | 15 qtrssince 2019-Q3 | Unchanged 0 | |
Horizon Pharma Plc | 500,000 | $51.4M | 5.0% | — | — | 15 qtrssince 2019-Q3 | Decreased 0 |
THRYV HLDGS INC | 2M | $49.2M | 4.8% | $13.03 | +91.86% | 10 qtrssince 2020-Q4 | Unchanged 0 |
Agnico Eagle Mines Ltd | 783,561 | $39.2M | 3.8% | $55.39 | -14.91% | 6 qtrssince 2022-Q1 | Unchanged 0 |
SSR Mining Inc | 2M | $28.4M | 2.8% | $15.89 | -11.78% | 15 qtrssince 2019-Q3 | Unchanged 0 |
International Tower Hill Mines | 61.9M | $25.7M | 2.5% | $0.55 | -32.93% | 15 qtrssince 2019-Q3 | Unchanged 0 |
Seabridge Gold Inc | 2.1M | $24.9M | 2.4% | $17.03 | -31.63% | 15 qtrssince 2019-Q3 | Unchanged 0 |
Newmont Mining Corp | 452,000 | $19.3M | 1.9% | $39.85 | -12.48% | 1 qtr | New 66 |
JDL GOLD CORP | 2.5M | $11.5M | 1.1% | $11.17 | -59.18% | 12 qtrssince 2020-Q2 | Unchanged 0 |
Trilogy Metals Inc | 14.3M | $8.5M | 0.8% | $1.67 | -64.67% | 15 qtrssince 2019-Q3 | Unchanged 0 |
Newmark Group Inc | 1.3M | $8M | 0.8% | $7.83 | -23.38% | 15 qtrssince 2019-Q3 | Unchanged 0 |
Tellurian Inc | 5.3M | $7.5M | 0.7% | — | — | 7 qtrssince 2021-Q4 | Unchanged 0 |
IAMGOLD Corp | 1.9M | $4.9M | 0.5% | $3.41 | -22.87% | 15 qtrssince 2019-Q3 | Unchanged 0 |
Alibaba Group Holding Ltd | 50,000 | $4.2M | 0.4% | $115.53 | -32.11% | 8 qtrssince 2021-Q3 | Unchanged 0 |
IVERIC bio Inc | 25,000 | $983,500 | 0.1% | — | — | 1 qtr | New 36 |
PAULSON & CO. INC. manages $1B across 21 positions as of Q2 2023. Top holdings: BHC (20.6%), AAMI (18.3%), PPTA (8.9%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Added 4 new positions, exited 3, trimmed 1. Top move: MDGL (NEW, conviction 93). Portfolio: $1.0B across 21 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR